+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound muscle action potential amplitude and distal potential duration in axonal neuropathy



Compound muscle action potential amplitude and distal potential duration in axonal neuropathy



Muscle and Nerve 49(1): 146-147




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269183

Download citation: RISBibTeXText

PMID: 24038120

DOI: 10.1002/mus.24065


Related references

Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy. Clinical Neurophysiology 123(10): 2099-2105, 2012

Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?. Muscle and Nerve 49(6): 895-899, 2014

Correlation between denervation activity and compound muscle action potential amplitude in hereditary motor and sensory neuropathy I and II. Electromyography and Clinical Neurophysiology 38(6): 343-347, 1998

Influence of different types of surface electrodes on amplitude, area and duration of the compound muscle action potential. Clinical Neurophysiology 110(12): 2171-2175, 2000

Distal compound muscle action potential abnormalities in acute inflammatory demyelinating neuropathy. Neurology 43(4 SUPPL 2): A323, 1993

Monocyte-to-high density lipoprotein ratio is associated with a decreased compound muscle action potential amplitude in patients with diabetic axonal polyneuropathy. Medicine 97(42): E12857, 2018

Amplitude, area and duration of the compound muscle action potential change in different ways over the length of the ulnar nerve. Clinical Neurophysiology 117(9): 2085-2092, 2006

Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. Journal of the Peripheral Nervous System 14(3): 151-158, 2010

Value of distal compound muscle action potential duration prolongation in acute inflammatory demyelinating polyneuropathy: a European perspective. Muscle and Nerve 43(5): 751-755, 2011

A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology 19(4): 638-642, 2012

Duration of the distal compound muscle action potential for diagnosis of chronic inflammatory demyelinating polyneuropathy: effects of low-cut filters. Journal of Clinical Neurophysiology 31(5): 441-443, 2015

Rituximab Improves Subclinical Temporal Dispersion of Distal Compound Muscle Action Potential in Anti-MAG/SGPG Neuropathy Associated with Waldenström Macroglobulinemia: A Case Report. Case Reports in Neurology 5(1): 34-39, 2013

Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: A Japanese-European multicenter prospective study. Clinical Neurophysiology 126(9): 1805-1810, 2015

Temperature effects on duration and amplitude of distal median nerve action potential. Journal of Applied Physiology 28(6): 808-812, 1970

Poster 57 Discrepancy Between Muscle Grade and Compound Muscle Action Potential Amplitude on Nerve Conduction Study: A Case Report. Pm & R 8(9s): S179-S180, 2016